PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CRL vs. XLV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


CRLXLV
YTD Return-8.65%9.17%
1Y Return27.00%17.76%
3Y Return (Ann)-17.66%4.88%
5Y Return (Ann)9.46%10.98%
10Y Return (Ann)13.01%9.94%
Sharpe Ratio0.701.75
Sortino Ratio1.252.45
Omega Ratio1.161.32
Calmar Ratio0.412.07
Martin Ratio1.367.72
Ulcer Index18.80%2.39%
Daily Std Dev36.56%10.51%
Max Drawdown-69.81%-39.18%
Current Drawdown-52.88%-6.02%

Correlation

-0.50.00.51.00.5

The correlation between CRL and XLV is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

CRL vs. XLV - Performance Comparison

In the year-to-date period, CRL achieves a -8.65% return, which is significantly lower than XLV's 9.17% return. Over the past 10 years, CRL has outperformed XLV with an annualized return of 13.01%, while XLV has yielded a comparatively lower 9.94% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-7.25%
2.98%
CRL
XLV

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CRL vs. XLV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Charles River Laboratories International, Inc. (CRL) and Health Care Select Sector SPDR Fund (XLV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CRL
Sharpe ratio
The chart of Sharpe ratio for CRL, currently valued at 0.70, compared to the broader market-4.00-2.000.002.004.000.70
Sortino ratio
The chart of Sortino ratio for CRL, currently valued at 1.25, compared to the broader market-4.00-2.000.002.004.006.001.25
Omega ratio
The chart of Omega ratio for CRL, currently valued at 1.16, compared to the broader market0.501.001.502.001.16
Calmar ratio
The chart of Calmar ratio for CRL, currently valued at 0.41, compared to the broader market0.002.004.006.000.41
Martin ratio
The chart of Martin ratio for CRL, currently valued at 1.36, compared to the broader market0.0010.0020.0030.001.36
XLV
Sharpe ratio
The chart of Sharpe ratio for XLV, currently valued at 1.75, compared to the broader market-4.00-2.000.002.004.001.75
Sortino ratio
The chart of Sortino ratio for XLV, currently valued at 2.45, compared to the broader market-4.00-2.000.002.004.006.002.45
Omega ratio
The chart of Omega ratio for XLV, currently valued at 1.32, compared to the broader market0.501.001.502.001.32
Calmar ratio
The chart of Calmar ratio for XLV, currently valued at 2.07, compared to the broader market0.002.004.006.002.07
Martin ratio
The chart of Martin ratio for XLV, currently valued at 7.72, compared to the broader market0.0010.0020.0030.007.72

CRL vs. XLV - Sharpe Ratio Comparison

The current CRL Sharpe Ratio is 0.70, which is lower than the XLV Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of CRL and XLV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
0.70
1.75
CRL
XLV

Dividends

CRL vs. XLV - Dividend Comparison

CRL has not paid dividends to shareholders, while XLV's dividend yield for the trailing twelve months is around 1.54%.


TTM20232022202120202019201820172016201520142013
CRL
Charles River Laboratories International, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XLV
Health Care Select Sector SPDR Fund
1.54%1.59%1.47%1.33%1.49%2.17%1.58%1.47%1.60%1.43%1.35%1.52%

Drawdowns

CRL vs. XLV - Drawdown Comparison

The maximum CRL drawdown since its inception was -69.81%, which is greater than XLV's maximum drawdown of -39.18%. Use the drawdown chart below to compare losses from any high point for CRL and XLV. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-52.88%
-6.02%
CRL
XLV

Volatility

CRL vs. XLV - Volatility Comparison

Charles River Laboratories International, Inc. (CRL) has a higher volatility of 15.62% compared to Health Care Select Sector SPDR Fund (XLV) at 3.06%. This indicates that CRL's price experiences larger fluctuations and is considered to be riskier than XLV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
15.62%
3.06%
CRL
XLV